Recordati stock gains 1.6 percent as takeover offer nears majority

Published on 09/22/2026 at 18:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Recordati stock closed at EUR 52.37 on September 21, 2026, up 1.6 percent as tender offer acceptance reached 49.6 percent. Half-year revenue growth remained positive.

Moderne Pharma-Produktionsanlage mit Edelstahltanks und Glasfassade bei Tageslicht — Recordati S.p.A. (IT0003828271) betreibt moderne Pharma-Produktionsanlagen mit hochwertiger Fertigungstechnik am Firmensitz in Mailand, Italien, Illustration mit AI erstellt.

Recordati S.p.A. (ISIN IT0003828271) closed at EUR 52.37 in Milan on September 21, 2026, gaining 1.6 percent as acceptance of the takeover offer reached 49.6 percent. The combination of a price near the offer economics and a threshold close to majority ownership makes the tender process the immediate driver for the shares.

Takeover acceptance nears majority

According to ad-hoc-news.de on September 21, 2026, acceptance of the offer stood at 49.6 percent. That leaves 50.4 percent outside the reported acceptance total, so the next disclosures on participation and governance remain material to the share price.

The Milan close of EUR 52.37 represented a 1.60 percent increase from the previous trading day. The shares changed hands at 5:35 p.m. local time, providing a completed-session reference rather than an intraday estimate.

Half-year growth supports the case

For the first six months of 2026, Recordati reported consolidated revenue growth in the mid-single-digit to low-double-digit range versus the first half of 2025, according to the company information summarized by ad-hoc-news.de. Operating profit and net income also increased in the six-month period compared with the same period of 2025.

That comparison gives the takeover story an operating counterweight: the stock is not being assessed only against the offer process, but also against a business that expanded revenue, operating profit and net income in the first half of 2026. The reported growth range is qualitative rather than a single percentage, so the acceptance rate remains the clearest current numerical measure of the transaction.

Stock closes at EUR 52.37

Recordati stock closed at EUR 52.37 on Borsa Italiana in Milan on September 21, 2026, up 1.60 percent from the prior close. The market capitalization was described as being in the multi-billion-euro range as of September 21, 2026, placing the company among Italy's larger listed pharmaceutical businesses.